Document:

Exhibit 10.1

 

LICENSE AGREEMENT

 

Between

 

BBD HEALTHCARE STRATEGIES, LLC

 

And

 

FREEDOM LEAF, INC.

 

This License Agreement
(“Agreement”), dated as of March 31, 2017 (the “Effective Date”), is by and between Freedom
Leaf, Inc, a Nevada corporation located at 3571 East Sunset Rd., Suite 420, Las Vegas, Nevada, 89120 (“Licensor”),
and BBD Healthcare Strategies, LLC, a Florida Limited Liability Company, located at 2400 East Commercial Blvd., Suite 101, Ft.
Lauderdale, Florida 33308 (“Licensee”).

 

WHEREAS, Licensor
is the sole and exclusive owner of and has the right to license to Licensee distribution rights to the Freedom Leaf, Inc. magazine
as well as other “Freedom Leaf” branded merchandise and services (the “Distribution Rights,” as
defined below) in the Territory (as defined below); and

 

WHEREAS, Licensee
wishes to license the Distribution Rights from Licensor, and Licensor is willing to grant to Licensee a license to the Distribution
Rights on the terms and conditions set out in this Agreement.

 

NOW, THEREFORE, in
consideration of the mutual covenants, terms and conditions set forth herein, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1. Definitions. For purposes of
this Agreement, the following terms shall have the following meanings:

 

“Action” has the meaning
set forth in Section 11.1.

 

“Affiliate”
of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by,
or is under common control with, such Person. The term “control” (including the terms “controlled by” and
“under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction
of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 

“Bankruptcy Code” has
the meaning set forth in Section 13.1.

 

“Business
Day” shall mean any day of the year that is not a Saturday, Sunday or a day on which commercial banks in California are
authorized or required by law to close.

 

 

 

    	 	1	 

     

    

 

“Confidential
Information” means any information that is treated as confidential by either party, including trade secrets, technology,
information pertaining to business operations and strategies, and information pertaining to customers, pricing and marketing, in
each case to the extent it is: (a) if in tangible form, marked as confidential; or (b) otherwise, identified at the time of disclosure
as confidential and confirmed in writing as such within two (2) days after disclosure. Without limiting the foregoing, Confidential
Information of Licensee includes the terms and existence of this Agreement. Confidential Information does not include information
that the Receiving Party can demonstrate by documentation: (w) was already known to the Receiving Party without restriction on
use or disclosure prior to receipt of such information directly or indirectly from or on behalf of the Disclosing Party; (x) was
or is independently developed by the Receiving Party without reference to or use of any of the Disclosing Party’s Confidential
Information; (y) was or becomes generally known by the public other than by breach of this Agreement by, or other wrongful act
of, the Receiving Party or any of its Representatives; or (z) was received by the Receiving Party from a Third Party who was not,
at the time, under any obligation to the Disclosing Party or any other Person to maintain the confidentiality of such information.

 

“Distribution
Rights” means the publishing and distribution rights to the Freedom Leaf, Inc. Magazine as well as the right to sell
or offer to sell other “Freedom Leaf” branded products and services (the “Freedom Leaf Products and Services”),
as licensed pursuant to Section 2.

 

“Distribution
Rights IP” means the Intellectual Property used in conjunction with the Distribution Rights, including any Improvements
thereto and such intellectual property set forth on Schedule 1.

 

“Effective
Date” has the meaning set forth in the preamble.

 

“Improvement”
means (a) any new or modified distribution rights that have the same function as any of the Distribution Rights but (i) is better
or more economical; (ii) is more marketable than the Distribution Rights for any reason; or (b) any enhancement or modification
to the Distribution Rights and the underlying.

 

“Indemnitee”
has the meaning set forth in Section 11.1.

 

“Intellectual
Property” means shall mean all patents, trademarks, trade names, service marks, service names, trade dress, logos, copyrights
and domain names, and any registrations, applications and renewals for any of the foregoing, and all other intellectual property
rights in inventions, trade secrets, manufacturing processes, technology, know-how, confidential and proprietary information,
ideas, developments, drawings, specifications, bills of material, supplier lists, marketing information, sales and promotional
information, business plans, computer software (whether in object code (i.e., machine-readable) or source code (i.e., readable
and understandable by a programmer of ordinary skill) form) and all programmer notes and other documentation and tools that would
allow a programmer of ordinary skill to maintain, enhance, and create derivative works of such software, test reports, component
lists, manuals, instructions, catalogs, processes, designs, and registrations and applications for registration therefor, model
numbers, telephone numbers, web addresses, web sites, electronic records of drawings and tooling and other electronic engineering
tools, and all other proprietary rights, in each case owned or licensed by such person or used in such person’s business.

 

 

 

    	 	2	 

     

    

 

“Law”
means any statute, law, ordinance, regulation, rule, code, order, constitution, treaty, common law, judgment, award, decree, other
requirement or rule of law of any federal, state, local or foreign government or political subdivision thereof, or any arbitrator,
court or tribunal of competent jurisdiction.

 

“Licensee”
has the meaning set forth in the preamble. “Licensor” has the meaning set forth in the preamble.

 

“Losses”
means all losses, damages, liabilities, deficiencies, claims, actions, judgments, settlements, interest, awards, penalties, fines,
costs or expenses of whatever kind, including reasonable attorneys’ fees and the cost of enforcing any right to indemnification
hereunder and the cost of pursuing any insurance providers.

 

“Person”
means an individual, corporation, partnership, joint venture, limited liability company, governmental authority, unincorporated
organization, trust, association or other entity.

 

“Representatives”
means a Party’s and its Affiliates’ employees, officers, directors, consultants and legal advisors.

 

“Term”
has the meaning set forth in Section 12.1.

 

“Territory” means the State of Florida

 

2. Grant.

 

2.1       Scope
of Grant. Subject to the terms and conditions of this Agreement, Licensor hereby irrevocably grants to Licensee during the
Term a perpetual, exclusive right and license to the Distribution Rights in the Territory.

 

2.2 Restrictions
on Licensor. Licensor shall not grant others the Distribution Rights in the Territory other than explained in Section 2.3.

 

 

 

    	 	3	 

     

    

 

2.3Sublicensing. Licensor
hereby grants to Licensee the right to grant sublicenses of any of its rights under the Distribution Rights in accordance with
the terms of this Agreement. The granting of sublicenses shall be at the direction of the Licensor as to how many may be granted
in the Territory, but Licensee shall have the power to determine the identity of any sublicensee subject to the written approval
of the Licensor, which approval shall not be unreasonably withheld by Licensor. All of the applicable licensee fees or royalty
rates, if any, and other terms and conditions of the sublicense shall be determined solely by the Licensor.

 

2.4 Publicity.
Licensee shall develop all of its publicity and publications of advertising and marketing materials within the Territory related
to the licenses granted hereunder, which publicity and publications must be approved by Licensor, and which approval shall not
be unreasonably withheld by Licensor.

 

2.5 Trademarks.
Licensee shall have the right to select and use Licensors’ trademarks to identify the products relating to the Distribution
Rights. Licensee acknowledges the ownership of such trademarks in Licensor and agrees that except for as expressly set forth herein,
nothing in this Agreement shall be construed to grant Licensee any right, title or interest in or to any trademark used by Licensee
or registered in the name of Licensor.

 

3.       Warrants.
In partial consideration of the License payments to be made by Licensee pursuant to Section 4 below, Licensor shall grant
Licensee Cashless Warrants to purchase one million (1,200,000) shares of restricted Common Stock of Licensor. The exercise price
of said shares shall be $0.05/share, and the warrants shall only be exercisable in the following amounts and during the following
exercise periods and only if all payments required by Section 4 below have been fully paid in compliance with all of the
requirements in Section 4 and the schedules referenced therein:

 

3.1     240,000 shares between September
1, 2017 and October 31, 2017.

 

3.2     240,000 shares between November 1,
2017 and December 31, 2017.

 

3.3     240,000 shares between January 1, 2018
and February 28, 2018.

 

3.4     240,000 shares between March 1, 2018
and May 30, 2018.

 

3.5     240,000 shares between June 1, 2018
and July 30, 2018

 

4. Payments.

 

4.1 Payments.
It is agreed by both parties to the following payments by the Licensee to the Licensor. The Licensee will pay to Licensor Two Hundred
Fifty Thousand Dollars ($250,000) pursuant to the terms listed in Schedule 2, attached hereto and incorporated by reference
herein. Said payments are earned as of the date of this Agreement.

 

 

 

    	 	4	 

     

    

 

4.2 Royalty.
Continuing royalty fees shall be due and payable to the Licensor from the Licensee pursuant to the terms listed in Schedule
3, attached hereto and incorporated by reference herein.

 

5.       Prosecution
and Maintenance.

 

5.1 Infringement;
Patent Protection and Maintenance. Licensor shall from time to time take all steps which it reasonably considers necessary
to protect its rights to the Distribution Rights of Liscensee, and the Licensee agrees forthwith to communicate to the Licensor
any infringements or threatened infringements of the Licensor’s Distribution Rights which may come to its notice. Licensor
shall have no obligation to maintain or enforce any patents that may issue and become part of the Distribution Rights and nothing
in this Section 5.1 shall impose upon a Licensor any obligation to incur any expense in enforcing the Distribution Rights.

 

5.2 Patent Applications
and Maintenance. Licensor will have sole authority and discretion to make decisions relating to whether and how to apply for,
prosecute, obtain, maintain and renew the patents and applications included in the Licensor’s Distribution Rights. Licensor
shall promptly notify Licensee if Licensor declines to (i) apply for a patent, copyright, or trademark with respect to the Distribution
Rights for any jurisdiction that Licensee requests that an application be submitted, (ii) pursue prosecution of such application
that is included in such Distribution Rights, or (iii) maintain or renew any patents included in the Distribution Rights. Following
such notice, Licensee may, with notice to Licensor, elect to apply for a patent in such jurisdiction, or continue the prosecution
of such patent application (or maintenance of such patent) at Licensee’s expense, provided, however, that Licensor shall
retain all ownership rights to any patents that may issue with respect to such Distribution Rights.

 

6.       Third-Party
Infringement.

 

6.1 A party receiving
notice of alleged infringement of any Distribution Rights in the Territory, or having a declaratory judgment action alleging invalidity
or noninfringement of any Distribution Rights in the Territory brought against it, shall promptly provide written notice to the
other party of the alleged infringement or declaratory judgment action, as applicable.

 

6.2 Licensor shall
bring suit or defend a declaratory judgment action and control the conduct thereof, including settlement, to stop infringement
of any Distribution Rights, as determined solely by Licensor.

 

7.       Compliance
with Laws.

 

7.1 Marking.
Licensee shall comply with the patent, copyright and trademark marking provisions of 35 U.S.C. § 287(a) by marking all commercial
products and advertising relating to the Distribution Rights with the appropriate symbols or word markings. Licensee shall comply
with the intellectual property marking laws of each country in the Territory Licensee uses, markets or sells the Distribution Rights.

 

 

 

    	 	5	 

     

    

 

 

7.2 Regulatory
Clearance. Licensor shall reasonably cooperate with Licensee in obtaining any clearances from governmental agencies to use,
market or sell the Distribution Rights.

 

7.3       Recordation
of License. Licensor shall record this Agreement as required by the laws of United States and any other countries as Licensee
may request as a prerequisite to enforceability of this Agreement in the courts of such countries or for other reasons and any
recordation fees, and related costs and expenses shall be at Licensee’s expense.

 

8. Confidentiality.

 

8.1 Confidentiality
Obligations. Each party (the “Receiving Party”) acknowledges that in connection with this Agreement it
will gain access to Confidential Information of the other party (the “Disclosing Party”). As a condition to
being furnished with Confidential Information, the Receiving Party agrees, during the Term and all times thereafter, to:

 

(a)       not
use the Disclosing Party’s Confidential Information other than as strictly necessary to exercise its rights and perform its
obligations under this Agreement; and

 

(b)       maintain
the Disclosing Party’s Confidential Information in strict confidence and, subject to Section 8.2, not disclose the
Disclosing Party’s Confidential Information without the Disclosing Party’s prior written consent, provided, however,
the Receiving Party may disclose the Confidential Information to its Representatives who:

 

		(i)	have a “need to know” for purposes of the Receiving Party’s performance, or exercise
of its rights with respect to such Confidential Information, under this Agreement;

 

		(ii)	have been apprised of this restriction; and

 

		(iii)	are themselves bound by written
nondisclosure agreements at least as restrictive as those set forth in this Section 8, provided further that the Receiving
Party shall be responsible for ensuring its Representatives’ compliance with, and shall be liable for any breach by its
Representatives of, this Section 8.

 

The Receiving Party shall use reasonable
care, at least as protective as the efforts it uses with respect to its own confidential information, to safeguard the Disclosing
Party’s Confidential Information from use or disclosure other than as permitted hereby.

 

8.2 Exceptions.
Notwithstanding anything to the contrary herein, Licensee shall be expressly permitted to reference this Agreement and the terms
hereof in disclosure documents required by securities laws, and in other regulatory, administrative filings and public relations
materials in the ordinary course of Licensee’s business, and in marketing materials relating to the Distribution Rights,
without consent of the Licensor. Additionally, if the Receiving Party becomes legally compelled to disclose any Confidential Information,
the Receiving Party shall:

 

 

 

    	 	6	 

     

    

 

(a)       provide
prompt written notice to the Disclosing Party so that the Disclosing Party may seek a protective order or other appropriate remedy
or waive its rights under this Section 8; and

 

(b)       disclose
only the portion of Confidential Information that it is legally required to furnish.

 

If a protective order
or other remedy is not obtained, or the Disclosing Party waives compliance, the Receiving Party shall, at the Disclosing Party’s
expense, use reasonable efforts to obtain assurance that confidential treatment will be afforded the Confidential Information.

 

9. Representations; Warranties; Covenants.

 

9.1 Mutual Representations
and Warranties. Each party represents and warrants to the other party that:

 

(a)       it
is duly organized, validly existing and in good standing as a corporation or other entity as represented herein under the laws
and regulations of its jurisdiction of incorporation, organization or chartering;

 

(b)       it
has, and throughout the Term shall retain, the full right, power and authority to enter into this Agreement and to perform its
obligations hereunder;

 

(c)       the
execution of this Agreement by its representative whose signature is set forth at the end hereof has been duly authorized by all
necessary corporate action of the party; and

 

(d)       when
executed and delivered by such party, this Agreement shall constitute the legal, valid and binding obligation of that party, enforceable
against that party in accordance with its terms.

 

9.2 Licensor’s
Representations, Warranties, and Covenants. Licensor represents, warrants and covenants that:

 

(a)       Licensor
is the sole and exclusive owner of the Distribution Rights and has the right to grant Licensee the license granted under the Agreement,
without any conflict or breach of any other material agreement or understanding between Licensor and any other entity;

 

(b)       it
has, and throughout the Term, will retain the unconditional and irrevocable right, power and authority to grant the license hereunder;

 

(c)       neither
its grant of the license, nor its performance of any of its obligations, under this Agreement does or will at any time during the
Term:

 

	 	(i)	conflict with or violate any applicable Law;

 

 

 

    	 	7	 

     

    

 

		(ii)	require the consent, approval or authorization of any governmental or regulatory authority or other
third party; or

 

		(iii)	require the provision of any payment or other consideration to any third party.

 

(d) it has not granted
and will not grant any licenses or other contingent or non-contingent right, title or interest under or relating to the Distribution
Rights, or is or will be under any obligation, that does or will conflict with or otherwise affect this Agreement, including any
of Licensor’s representations, warranties or obligations or Licensee’s rights or licenses hereunder;

 

(e) there neither are
nor at any time during the Term will be any encumbrances, liens or security interests involving any Distribution Rights;

 

(f) no prior art or
other information exists that would adversely affect the validity, enforceability, term or scope of any Distribution Rights;

 

(g) it has no knowledge
after reasonable investigation of any settled, pending or threatened litigation or re-examination, post-grant or inter partes
review, interference, derivation, opposition, claim of invalidity or other claim or proceeding (including in the form of any
offer to obtain a license):

 

		(i)	alleging the invalidity, misuse, unregistrability, unenforceability or noninfringement of any Distribution
Rights;

 

		(ii)	challenging Licensor’s ownership of, or right to practice or license, any Distribution Rights,
or alleging any adverse right, title or interest with respect thereto; or

 

		(iii)	alleging that the practice of any Distribution Rights or the making, using, offering to sell, sale
or importation of any Distribution Rights in the Territory does or would infringe, misappropriate or otherwise violate any patent,
trade secret or other intellectual property of any third party.

 

(h) it has no knowledge
after reasonable investigation of any factual, legal or other reasonable basis for any litigation, claim or proceeding described
in Section 9.2(g);

 

(i) it has not received
any written, oral or other notice of any litigation, claim or proceeding described in Section 9.2(g); and

 

(j) it has not brought
or threatened any claim against any third party alleging infringement of any Distribution Rights, nor is any third party infringing
or preparing or threatening to infringe any patent, or practicing any claim of any patent application, included as a Distribution
Rights.

 

 

 

    	 	8	 

     

    

 

10.       Omitted

 

11.       Indemnification.

 

11.1 Each party shall
indemnify, defend and hold harmless the other party and its officers, directors, employees, agents, successors and assigns (each,
an “Indemnitee”) against all Losses arising out of or resulting from any third party claim, suit, action or
proceeding related to or arising out of or resulting from the party’s breach of any representation, warranty, covenant or
obligation under this Agreement (each an “Action”).

 

11.2 Omitted.

 

11.3 Indemnification
Procedure. The indemnified party shall promptly notify the indemnifying party in writing of any Action and cooperate with the
indemnified party at the indemnifying party’s sole cost and expense. The indemnifying party shall immediately take control
of the defense and investigation of the Action and shall employ counsel reasonably acceptable to indemnified party to handle and
defend the same, at the indemnifying party’s sole cost and expense. The indemnifying party shall not settle any Action in
a manner that adversely affects the rights of any indemnified party without the indemnified party’s prior written consent,
which shall not be unreasonably withheld or delayed. The indemnified party’s failure to perform any obligations under this
Section 11.3 shall not relieve the indemnifying party of its obligation under this Section 11.3 except to the extent
that the indemnifying party can demonstrate that it has been prejudiced as a result of the failure. The indemnified party may participate
in and observe the proceedings at its own cost and expense with counsel of its own choosing.

 

12.       Term
and Termination.

 

12.1 Term.
This Agreement shall commence as of the Effective Date and, unless terminated earlier in accordance with Section 12.2, the
licenses granted hereunder shall be perpetual (the “Term”).

 

12.2 Termination.

 

(a)       Licensor
may terminate this Agreement on written notice to Licensee if Licensee materially breaches Section 4.1 of this Agreement
and such breach remains uncured for twenty (20) days after Licensee receives written notice thereof.

 

(b)       Licensee
may terminate this Agreement at any time without cause, and without incurring any additional obligation, liability or penalty,
by providing at least twenty (20) days’ prior written notice to Licensor.

 

 

 

    	 	9	 

     

    

 

(c) Either party may
terminate this Agreement by written notice to the other party if the other party:

 

		(i)	becomes insolvent or admits inability to pay its debts generally as they become due;

 

		(ii)	becomes subject, voluntarily or involuntarily, to any proceeding under any domestic or foreign
bankruptcy or insolvency law, which is not fully stayed within One Hundred Eighty (180) days or is not dismissed or vacated within
One Hundred Eighty (180) days after filing;

 

		(iii)	makes a general assignment for the benefit of creditors; or

 

		(iv)	has a receiver, trustee, custodian or similar agent appointed by order of any court of competent
jurisdiction to take charge of or sell any material portion of its property or business.

 

(d) Any termination
made does not relinquish the Licensee from its responsibility to pay any unpaid portions of the licensing fee. The licensing fee
is payable in the event of termination.

 

12.3 Effect of
Termination. On termination of this Agreement, the Receiving Party shall (a) return to the Disclosing Party all documents and
tangible materials (and any copies) containing, reflecting, incorporating or based on the Disclosing Party’s Confidential
Information; (b) permanently erase the Disclosing Party’s Confidential Information from its computer systems and (c) certify
in writing to the Disclosing Party that it has complied with the requirements of this Section 12.3.

 

12.4 Survival.
The rights and obligations of the parties set forth in this Section 12.4 and Section 1 (Definitions), Section
8 (Confidentiality), Section 9 (Representations and Warranties), Section 11 (Indemnification), Section 12.3
(Effect of Termination), and Section 13 (Miscellaneous), and any right, obligation or required performance of the parties
in this Agreement which, by its express terms or nature and context is intended to survive termination or expiration of this Agreement,
will survive any such termination or expiration.

 

13. Miscellaneous.

 

13.1 Bankruptcy.
The Parties acknowledge and agree that all rights and licenses granted pursuant to this Agreement are, for purposes of
Section 365(n) of Title 11 of the United States Code (or any successor provision) (the “Bankruptcy
Regulations”) “intellectual property” as defined in Section 101(35A) of the United States Bankruptcy
Code (the “Code”), which has been licensed hereunder in a contemporaneous exchange for value. The Parties further
acknowledge and agree that if a Licensor becomes insolvent, applies for or consents to the appointment of a trustee, makes a
general assignment for the benefit of its creditors, commences, or has commenced against it, any bankruptcy, reorganization,
debt arrangement, or other proceeding under bankruptcy law or elects to reject this Agreement, or if this Agreement is deemed
to be rejected, pursuant to Section 365 of the Code for any reason, this Agreement shall be governed by Section 365(n) of the
Code and each Party as a Licensee hereunder will retain and may elect to fully exercise its rights under this Agreement in
accordance with such Section 365(n).

 

 

 

    	 	10	 

     

    

 

13.2 Further Assurances.
Each party shall, upon the request of the other party, promptly execute such documents and perform such acts as may be necessary
to give full effect to the terms of this Agreement.

 

13.3 Independent
Contractors. The relationship between the parties is that of independent contractors. Nothing contained in this Agreement shall
be construed as creating any agency, partnership, joint venture or other form of joint enterprise, employment or fiduciary relationship
between the parties, and neither party shall have authority to contract for or bind the other party in any manner whatsoever.

 

13.4 Omitted.

 

13.5 Notices.
All notices and other communications hereunder shall be in writing and shall be deemed given when mailed, delivered personally,
sent by facsimile (which is confirmed) or sent by an overnight courier service, such as Federal Express, to the parties at the
following addresses (or at such other address for a party as shall be specified by such party by like notice):

 

If to Licensee, to:

 

Joan Portela

BBD Healthcare Strategies LLC

2400 East Commercial Blvd, Suite 101

Ft. Lauderdale, FL 33308

Tel: +1-954-449-6018

email: jportela@teambiovis.com

 

If to Licensor, to:

 

Mr. Clifford J Perry

Freedom Leaf, Inc.

3571 E Sunset Rd., Suite 420

Las Vegas, CA 89120

Tel: 954-895-3316

email: cliff@freedomleaf.com

 

 

 

    	 	11	 

     

    

 

13.6 Interpretation.
For purposes of this Agreement, (a) the words “include,” “includes” and “including” shall be
deemed to be followed by the words “without limitation”; (b) the word “or” is not exclusive; and (c) the
words “herein,” “hereof,” “hereby,” “hereto” and “hereunder” refer
to this Agreement as a whole.

 

Unless the context
otherwise requires, references herein: (x) to Sections and Schedules refer to the Sections of and Schedules attached to, this Agreement;
(y) to an agreement, instrument or other document means such agreement, instrument or other document as amended, supplemented and
modified from time to time to the extent permitted by the provisions thereof; and (z) to a statute means such statute as amended
from time to time and includes any successor legislation thereto and any regulations promulgated thereunder. This Agreement shall
be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument
or causing any instrument to be drafted. Any Schedules referred to herein shall be construed with, and as an integral part of,
this Agreement to the same extent as if they were set forth verbatim herein.

 

13.7 Headings.
The headings in this Agreement are for reference only and shall not affect the interpretation of this Agreement.

 

13.8 Entire Agreement.
This Agreement, together with all Schedules and any other documents incorporated herein by reference, constitutes the sole and
entire agreement of the parties to this Agreement with respect to the subject matter contained herein, and supersedes all prior
and contemporaneous understandings and agreements, both written and oral, with respect to such subject matter.

 

13.9 Assignment.
Licensee may freely assign or otherwise transfer all or any of its rights, or delegate or otherwise transfer all or any of its
obligations or performance, under this Agreement without Licensor’s consent. This Agreement is binding upon and inures to
the benefit of the parties hereto and their respective permitted successors and assigns.

 

13.10No
Third-Party Beneficiaries. This Agreement is for the sole benefit of the parties hereto and their respective successors
and permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person any legal
or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Agreement.

 

13.11Amendment; Modification;
Waiver. This Agreement may only be amended, modified or supplemented by an agreement in writing signed by each party hereto.
No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by
the waiving party. Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights,
remedy, power or privilege arising from this Agreement shall operate or be construed as a waiver thereof; nor shall any single
or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise
of any other right, remedy, power or privilege.

 

 

 

    	 	12	 

     

    

 

13.12Severability. If any
term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability
shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in
any other jurisdiction. Upon a determination that any term or other provision is invalid, illegal or unenforceable, the parties
hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as
possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated
to the greatest extent possible.

 

13.13Governing Law; Submission
to Jurisdiction.

 

(a)       This
Agreement and all related documents, and all matters arising out of or relating to this Agreement, are governed by, and construed
in accordance with, the laws of the State of Nevada, United States of America, without regard to the conflict of laws provisions
thereof to the extent such principles or rules would require or permit the application of the laws of any jurisdiction other than
those of the State of Nevada.

 

(b)       Any
legal suit, action or proceeding arising out of or related to this Agreement or the licenses granted hereunder shall be instituted
exclusively in the federal courts of the United States or the courts of the State of Nevada in each case located in the city of
Las Vegas, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding.
Service of process, summons, notice or other document by mail to such party’s address set forth herein shall be effective
service of process for any suit, action or other proceeding brought in any such court.

 

13.14Waiver of Jury Trial.
Each party irrevocably and unconditionally waives any right it may have to a trial by jury in respect of any legal action arising
out of or relating to this Agreement or the transactions contemplated hereby.

 

13.15Equitable Relief. Each
party acknowledges that a breach by the other party of this Agreement may cause the non-breaching party irreparable harm, for which
an award of damages would not be adequate compensation and agrees that, in the event of such a breach or threatened breach, the
non-breaching party will be entitled to equitable relief, including in the form of a restraining order, orders for preliminary
or permanent injunction, specific performance and any other relief that may be available from any court, and the parties hereby
waive any requirement for the securing or posting of any bond or the showing of actual monetary damages in connection with such
relief. These remedies shall not be deemed to be exclusive but shall be in addition to all other remedies available under this
Agreement at law or in equity, subject to any express exclusions or limitations in this Agreement to the contrary.

 

13.16Attorney Fees. In the
event that any action, suit, or other legal or administrative proceeding is instituted or commenced by either party hereto against
the other party arising out of or related to this Agreement, the prevailing party shall be entitled to recover its reasonable attorneys’
fees and court costs from the non-prevailing party.

 

 

 

 

    	 	13	 

     

    

 

13.17       Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be
deemed to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, e-mail or other means of
electronic transmission (to which a signed PDF copy is attached) shall be deemed to have the same legal effect as delivery of
an original signed copy of this Agreement.

 

 

[SIGNATURE PAGE FOLLOWS]

 

 

 

 

 

    	 	14	 

     

    

 

IN WITNESS WHEREOF, each
of the parties hereto has executed this License Agreement as of the date first above written.

 

	 	LICENSEE:
	 	 
	 	BBD Healthcare Strategies LLC
	 	 
	 	 
	 	By:    /s/ Joan Portela
	 	Joan Portela 
	 	Manager
	 	 
	 	 
	 	LICENSOR:
	 	 
	 	Freedom Leaf, Inc.
	 	 
	 	 
	 	By:  /s/ Clifford J. Perry
	 	Clifford J. Perry 
	 	CEO

 

 

 

 

[Signature Page to License Agreement]

 

 

 

    	 	15	 

     

    

 

SCHEDULE 1

 

IP RELATING TO DISTRIBUTION RIGHTS

 

Licensee will publish and/or distribute
the Freedom Leaf Magazine within Territory. The magazines to be distributed will include a section for and about the Cannabis news
in the Territory. Licensee will also write articles for said section and Licensee is required to sell 10 (ten) pages at the rates
listed in the Freedom Leaf Rate Card. These ads will be placed in the above-mentioned section. The income from all advertising
sales for this section will be split between the Licensee and Licensor equally on a 50% (fifty percent) basis for each. Any sales
of advertising in the remainder of the Freedom Leaf Magazine completed by the Licensee will provide a 25% (twenty five percent)
commission to the Licensee.

 

Licensee will have Freedom Leaf, Inc. Press
Credentials useable within Territory.

 

Licensee will purchase Freedom Leaf, Inc.
Branded products, such as T-Shirts, hats, artwork, stickers, cosmetics, vapors and other products as they become available. All
products will have wholesale prices available to Licensee.

 

Licensee will have services available from
Freedom Leaf, Inc. to sell such as speakers for seminars, consulting, advertising, social media, and other services that become
available.

 

Any products and services other than those
provided by Freedom Leaf, Inc. that are to be introduced in the Territory must be approved by Licensor.

 

Products and/or Services that are under
exclusive or nonexclusive distribution agreements between Licensor that are with outside vendors will be available for the Licensee
to sell under special commission basis that will be outlined for each Product or Service. If there is a restriction in a distribution
agreement from a vendor that restricts distribution of a product or service within the Licensee’s territory, that product
or service will not be available to the Licensee.

 

 

 

    	 	16	 

     

    

 

SCHEDULE 2

 

SCHEDULE OF PAYMENTS

 

Payment Terms:

 

	License Cost	$250,000  	 
	Downpayment	$25,000  	$225,000  
	Aug 2017 payment	$25,000  	$200,000  
	Oct 2017 payment	$25,000  	$175,000  
	Dec 2017 payment	$25,000  	$150,000  
	Feb 2018 payment	$25,000  	$125,000  
	Mar 2018 payment	$25,000  	$100,000  
	Apr 2018 payment	$25,000  	$75,000  
	May 2018 payment	$25,000  	$50,000  
	Jun 2018 payment	$50,000  	$  -  

 

 

It is recognized by the Licensor that
Licensee received $24,000 (Twenty four thousand dollars) from Biovis, Inc. Since Biovis Inc. has released this credit to the Licensee,
the Licensor is using this credit of Biovis Inc .along with $1,000 (One thousand dollars) in interest as the $25,000 (Twenty five
thousand dollar) down payment toward the cost of the License.

 

Biovis Inc. hereby releases above-mentioned
credit to Licensee: For Biovis Inc.

 

 

________________________

Signature

 

Joan Portela

Manager

 

 

 

 

 

 

 

 

 

 

    	 	17	 

     

    

 

SCHEDULE 3

 

ROYALTY FEES

 

The Royalty Fees that Licensee will pay
to the Licensor are:

 

All merchandise sales of merchandise purchased
from Licensor will carry a 5% (five percent) royalty fee.

 

All merchandise sales of merchandise purchased
from vendor other than Licensor will carry a 10% (ten percent) royalty fee. Licensor must approve of any merchandise from vendors
other than Licensor.

 

All seminars or conferences that are set
up and operated by the Licensee within their Territory will carry a royalty fee of 33% (thirty-three percent) of the gross profit
margin.

 

Other products and/or services that are
developed in the future will have appropriate royalty fees and will be included in this Schedule when those products and/or services
become available.

 

 

 

 

 

 

 

    	 	18Exhibit

EXHIBIT 10.1

NINTH AMENDMENT 
TO
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT

This NINTH AMENDMENT TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENT (this “Ninth Amendment”) dated as of March 31, 2017 (the “Ninth Amendment Effective Date”), is by and among SM ENERGY COMPANY, a corporation duly formed and existing under the laws of the State of Delaware (the “Borrower”); each of the Lenders that is a party hereto; and WELLS FARGO BANK, N.A., as administrative agent for the Lenders (in such capacity, together with its successors in such capacity, by operation of law or as otherwise provided herein, the “Administrative Agent”).

The parties hereto agree as follows:    

RECITALS
(A)    The Borrower, the Administrative Agent and the Lenders are party to that certain Fifth Amended and Restated Credit Agreement dated as of April 12, 2013 (as amended, supplemented, or otherwise modified prior to the date hereof, the “Credit Agreement”), pursuant to which the Lenders have made certain credit available to and on behalf of the Borrower; 
(B)    The Borrower, the Administrative Agents and the Lenders have agreed, among other things, to amend Sections 9.02 and 9.17 of the Credit Agreement to grandfather existing Debt and to permit the Borrower to hedge projected production based on internal production forecasts;
(C)    The Lenders have agreed to redetermine the Borrowing Base as provided herein, which redetermination of the Borrowing Base shall, upon its effectiveness, constitute the April 1, 2017 Scheduled Redetermination of the Borrowing Base.
Section 1.Defined Terms.  Each capitalized term that is defined in the Credit Agreement, but that is not defined in this Ninth Amendment, shall have the meaning ascribed to such term in the Credit Agreement.  Unless otherwise indicated, all section references in this Ninth Amendment refer to the Credit Agreement.
Section 2.    Amendments.  In reliance on the representations, warranties, covenants and agreements contained in this Ninth Amendment, and subject to the satisfaction of the conditions precedent set forth in Section 4 hereof, the Credit Agreement shall be amended, effective as of the Ninth Amendment Effective Date, in the manner provided in this Section 2.
2.1    Additional Definitions.  Section 1.02 of the Credit Agreement is hereby amended by inserting the following definitions in appropriate alphabetical order, which shall read in full as follows:
“Ninth Amendment Effective Date” means March 31, 2017.

1

“Projected Volume” means, at any time, the Borrower’s reasonably anticipated projected future production from Oil and Gas Properties of the Borrower and the other Loan Parties.
2.2    Amendment to Section 8.01 of the Credit Agreement.  Section 8.01 of the Credit Agreement is hereby amended to insert a new clause (p) thereto in alphabetical order which shall read in full in follows:
(p) Certificate of Financial Officer – Projected Volume Reports. (i) Concurrently with any delivery of financial statements under Section 8.01(a) and Section 8.01(b), (ii) promptly upon the occurrence of any event (including any sale, transfer, assignment or other disposition of Oil and Gas Properties) that the Borrower determines in its reasonable discretion would decrease the aggregate Projected Volume by 5% or more of the aggregate Projected Volume during the five-year period set forth in the most recent certificate previously delivered pursuant to this Section 8.01(p), and (iii) at the election of the Borrower, up to two times during the period following the delivery of the most recent certificate previously delivered pursuant to clause (i) above (or more frequently, if the Administrative Agent in its reasonable discretion approves), a certificate of a Financial Officer setting forth as of a recent date, a report detailing the Projected Volume for each month during the forthcoming five year period and the assumptions used in calculating such Projected Volume, in each case, in form and substance reasonably satisfactory to the Administrative Agent.  
2.3    Amendment to Section 8.12(a) of the Credit Agreement.  Section 8.12(a) of the Credit Agreement is hereby amended by amending and restating “most senior executive of the Borrower who is responsible for engineering and evaluation” with “most senior employee of the Borrower who has direct oversight for engineering and evaluation”.
2.4    Amendment to Section 8.12(b) of the Credit Agreement.  Section 8.12(b) of the Credit Agreement is hereby amended by amending and restating “Vice President, Engineering and Evaluation” with “most senior employee of the Borrower who has direct oversight for engineering and evaluation”.
2.5    Amendment to Section 9.02(c) of the Credit Agreement.  Section 9.02(c) of the Credit Agreement is hereby amended to amend and restate clause (ii) therein to read in full as “(ii) other than with respect to Debt set forth on Schedule 9.02(c) outstanding on the Ninth Amendment Effective Date, the aggregate principal amount of Debt permitted by this clause (c) shall not exceed $75,000,000 at any time outstanding.”
2.6    Amendment to Section 9.02(h) of the Credit Agreement.  Section 9.02(h) of the Credit Agreement is hereby amended and restated to read in full as follows:
(h) Debt set forth on Schedule 9.02(h) outstanding on the Ninth Amendment Effective Date and other Debt not to exceed $25,000,000 in the aggregate at any one time outstanding.
2.7    Amendment to Section 9.17 of the Credit Agreement.  Section 9.17 of the Credit Agreement is hereby amended and restated to read in full as follows:

2

Section 9.17 Swap Agreements.  No Loan Party will enter into any Swap Agreements with any Person other than:
(a) Subject to the second to last paragraph of this Section 9.17, Swap Agreements in respect of commodities (i) with an Approved Counterparty and (ii) the notional volumes for which (when aggregated with other commodity Swap Agreements then in effect) do not exceed (A) 85% of the Projected Volumes of each of (1) crude oil, (2) natural gas and (3) natural gas liquids and condensate, calculated separately, in each case based on the most recently delivered certificate under Section 8.01(p) for each month during the first thirty-six (36) month period from the date such Swap Agreement (including each trade or transaction) is executed and (B) 75% of the reasonably anticipated production of each of (1) crude oil, (2) natural gas and (3) natural gas liquids and condensate, calculated separately, in each case from the Loan Parties’ Proved Reserves included in the most recently delivered Reserve Report for each month during the twenty-four (24) month period commencing with the third anniversary of the date of such Swap Agreement (including each trade or transaction) is executed; provided, however, that such Swap Agreements shall not, in any case, have a tenor of longer than sixty (60) months, provided that the restrictions in the foregoing clauses (A) and (B) shall not apply to floor or put arrangements setting a minimum commodity price;

(b)    Swap Agreements effectively converting interest rates from floating to fixed (A) with an Approved Counterparty and (A) the notional amounts of which (when aggregated with other interest rate Swap Agreements then in effect effectively converting interest rates from floating to fixed) do not exceed 100% of principal amount of the Borrower’s floating rate Debt in respect of borrowed money;

(c)    Swap Agreements effectively converting interest rates from fixed to floating (i) with an Approved Counterparty and (ii) the notional amounts of which (when aggregated with other interest rate Swap Agreements then in effect effectively converting interest rates from fixed to floating) do not exceed 100% of principal amount of the Borrower's fixed rate Debt in respect of borrowed money;

(d)    Swap Agreements in respect of currencies (A) with an Approved Counterparty and (A) that are to hedge actual or expected fluctuations in currencies and are not for speculative purposes; and

(e)     Any Permitted Bond Hedge Transactions. 

In no event shall any Swap Agreement contain any requirement, agreement or covenant for any Loan Party to post collateral or margin to secure their obligations under such Swap Agreement or to cover market exposures other than usual and customary requirements to deliver letters of credit or post cash collateral.

3

For purposes of entering into or maintaining Swap Agreement trades or transactions under clause (a)(ii)(B) of this Section 9.17, forecasts of reasonably anticipated production from the Borrower's and the other Loan Parties’ Proved Reserves as set forth in the most recent Reserve Report delivered pursuant to the terms of this Agreement may be revised at the Borrower’s option to account for any increase or decrease therein anticipated because of information obtained by the Borrower or any other Loan Party subsequent to the publication of such Reserve Report, including the Borrower’s or any other Loan Party’s internal forecasts of production decline rates for existing wells and including additions to or deletions from anticipated future production due to new wells coming on stream or failing to come on stream, the shutting in of wells or other cessation of production from wells, the acquisition of property or wells and the disposition of property or wells.

If, at the end of any calendar month, the Borrower determines that the aggregate notional volumes of all Swap Agreements in respect of commodities for such calendar month (other than basis differential swaps on volumes already hedged pursuant to other Swap Agreements) exceeded 100% of actual production of each of (i) crude oil, (ii) natural gas and (iii) natural gas liquids and condensate, calculated separately, for such calendar month, then the Borrower shall (A) promptly notify the Administrative Agent of such determination, and (B) if requested by the Administrative Agent or the Supermajority Lenders, within 30 days after such request (1) provide an updated report of the type set forth in Section 8.01(p) and (2) terminate, create off-setting positions or otherwise unwind or monetize existing Swap Agreements such that, at such time, the volumes under commodity Swap Agreements will not exceed 100% of the Projected Volumes set forth in the report delivered pursuant to the foregoing clause (1) for the then-current and any succeeding calendar month covered by such Swap Agreements.

If, between Scheduled Redeterminations, any Loan Party assigns, terminates, or unwinds any Swap Agreements in respect of commodities which have, individually or in the aggregate, a value in the then effective Borrowing Base (as determined by the Administrative Agent) equal to more than five percent (5%) of the then effective Borrowing Base, the Borrowing Base shall be reduced, effective immediately, by an amount equal to the value, if any, assigned the liquidated portion of such Swap Agreements.

2.8    Amendment to Section 12.01(a)(i) of the Credit Agreement.  Section 12.01(a)(i) of the Credit Agreement is hereby amended and restated to read in full as follows:
(i)    if to the Borrower, to it at 1775 Sherman Street, Suite 1200, Denver, Colorado 80203, Attention: Treasury Department (Telecopy No. 303/861-0934) (E-mail Address: nmarkham@sm-energy.com);
2.9    Amendment to Schedules of the Credit Agreement.  The Credit Agreement shall be amended to insert Schedule 9.02(c) and Schedule 9.02(h) attached hereto as Schedule 9.02(c) and Schedule 9.02(h) thereto and Schedule 9.02(c) and Schedule 9.02(h) attached hereto shall be deemed to be attached as Schedule 9.02(c) and Schedule 9.02(h) to the Credit Agreement.

4

Section 3.    Redetermination of Borrowing Base.  The Lenders hereby agree that, for the period from and including the Ninth Amendment Effective Date to but excluding the next Redetermination Date, the amount of the Borrowing Base shall be equal to $925,000,000.00.  Notwithstanding the foregoing, the Borrowing Base may be subject to further adjustments from time to time pursuant to Section 2.07, Section 8.13(c), Section 9.02(i), Section 9.12, Section 9.17 or Section 9.18 of the Credit Agreement.  For the avoidance of doubt, the Borrower and the Lenders hereby agree that the redetermination herein shall constitute the April 1, 2017 Scheduled Redetermination of the Borrowing Base.  Concurrently with the redetermination of the Borrowing Base pursuant to this Section 3, the Aggregate Commitment shall be automatically reduced to $925,000,000.00 pursuant to Section 2.06(d) of the Credit Agreement and Annex I attached to the Credit Agreement shall be amended and restated in its entirety with Annex I attached hereto and Annex I attached hereto shall be deemed to be attached as Annex I to the Credit Agreement.  This Section 3 constitutes the New Borrowing Base Notice pursuant to Section 2.07(d) of the Credit Agreement for the April 1, 2017 Scheduled Redetermination of the Borrowing Base.
Section 4.    Conditions Precedent.  This Ninth Amendment shall be effective upon the date of the receipt by the Administrative Agent of the following documents and satisfaction of the other conditions provided in this Section 4, each of which shall be reasonably satisfactory to the Administrative Agent in form and substance:
4.1    Counterparts.  The Administrative Agent shall have received counterparts hereof duly executed by the Borrower and the Lenders constituting at least the Supermajority Lenders, which may be delivered by the means described in Section 6.3 (or, in the case of any party as to which an executed counterpart shall not have been received, email, facsimile, or other written or electronic confirmation from such party of execution of a counterpart hereof by such party).
4.2    Projected Volume Report.  The Administrative Agent shall have received a certificate of a Financial Officer setting forth a report detailing the Projected Volume for each month during the forthcoming five year period and the assumptions used in calculating such Projected Volume, in each case, in form and substance reasonably satisfactory to the Administrative Agent.  
4.3    Mortgage.  The Administrative Agent shall have received executed counterparts of Security Instruments granting to the Administrative Agent a first-priority Lien interest (subject only to Excepted Liens of the type described in clauses (a) to (d) of the definition thereof, but subject to the provisos at the end of such definition) on additional Oil and Gas Properties not already subject to a Lien of the Security Instruments such that, after giving effect thereto, the Mortgaged Properties will represent at least 90% of the Oil and Gas Properties evaluated in the most recently completed Reserve Report.
4.4    Title.  The Administrative Agent shall have received title information in form and substance acceptable to the Administrative Agent covering additional proved Oil and Gas Properties evaluated by the most recently completed Reserve Report such that, after giving effect thereto, the Administrative Agent shall have received reasonably satisfactory title information on at least 80% of the value of the Borrowing Base after giving effect to this Ninth Amendment (including Section 3 hereof).

5

4.5    No Event of Default or Deficiency.  No Event of Default shall have occurred which is continuing and the Aggregate Revolving Credit Exposures shall not exceed the Borrowing Base.
For purposes of determining satisfaction of the conditions specified in this Section 4, each Lender that has signed this Ninth Amendment shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required under this Section 4 to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the Ninth Amendment Effective Date specifying its objection thereto.  The Administrative Agent shall notify Borrower and each Lender of the Ninth Amendment Effective Date and such notice shall be conclusive and binding.
Section 5.    Reaffirm Existing Representations and Warranties.  The Borrower hereby (a) acknowledges the terms of this Ninth Amendment; (b) ratifies and affirms its obligations under, and acknowledges its continued liability under, each Loan Document to which it is a party and agrees that each Loan Document to which it is a party remains in full force and effect as expressly amended hereby; and (c) represents and warrants to the Lenders that, as of the date hereof, after giving effect to the terms of this Ninth Amendment: (i) all of the representations and warranties contained in each Loan Document to which the Borrower is a party are true and correct in all material respects as though made on and as of the Ninth Amendment Effective Date (unless made as of a specific earlier date, in which case, such representation or warranty was true and correct in all material respects as of such date or qualified by materiality, in which case such representation or warranty shall be true and correct as of the applicable date); (ii) no Default or Event of Default has occurred and is continuing and the Aggregate Revolving Credit Exposures do not, and will not immediately after giving effect to this Ninth Amendment, exceed the Borrowing Base; (iii) since the date of the most recent balance sheet delivered pursuant to Section 8.01(a) of the Credit Agreement, no Material Adverse Effect has occurred; (iv) the execution, delivery and performance by the Borrower of this Ninth Amendment are within Borrower’s corporate powers, have been duly authorized by all necessary corporate action, require no consent or approval of, or filing with, any governmental body, agency or official and do not violate  any provision of applicable law or any material agreement binding upon Borrower or any other Loan Party; and (v) this Ninth Amendment constitutes the valid and binding obligation of the Borrower enforceable in accordance with its terms, except as (A) the enforceability thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditor’s rights generally, and (B) the availability of equitable remedies may be limited by equitable principles of general application, regardless of whether considered in a proceeding in equity or at law. 
Section 6.    Miscellaneous.
6.1    Confirmation.  The provisions of the Credit Agreement (as amended by this Ninth Amendment) shall remain in full force and effect in accordance with its terms following the effectiveness of this Ninth Amendment.  This Ninth Amendment shall constitute a Loan Document.
6.2    No Waiver.  Neither the execution by the Administrative Agent or the Lenders party hereto of this Ninth Amendment, nor any other act or omission by the Administrative Agent or the Lenders or their officers in connection herewith, shall be deemed a waiver by the Administrative Agent or the Lenders of any Defaults or Events of Default which may exist, which may have occurred 

6

prior to the date of the effectiveness of this Ninth Amendment or which may occur in the future under the Credit Agreement and/or the other Loan Documents.  Similarly, nothing contained in this Ninth Amendment shall directly or indirectly in any way whatsoever either: (a) impair, prejudice or otherwise adversely affect the Administrative Agent’s or the Lenders’ right at any time to exercise any right, privilege or remedy in connection with the Loan Documents with respect to any Default or Event of Default, (b) except as provided herein, amend or alter any provision of the Credit Agreement, the other Loan Documents, or any other contract or instrument, or (c) constitute any course of dealing or other basis for altering any obligation of the Borrower or any right, privilege or remedy of the Administrative Agent or the Lenders under the Credit Agreement, the other Loan Documents, or any other contract or instrument.  Nothing in this Ninth Amendment shall be construed to be a consent by the Administrative Agent or the Lenders to any Default or Event of Default.  Each reference in the Credit Agreement to “this Agreement”, “hereunder”, “hereof”, “herein” or any other word or words of similar import shall mean and be a reference to the Credit Agreement as amended hereby, and each reference in any other Loan Document to the Credit Agreement or any word or words of similar import shall be and mean a reference to the Credit Agreement as amended hereby.
6.3    Counterparts.  This Ninth Amendment may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract.   Delivery of an executed signature page to this Ninth Amendment by facsimile transmission or other electronic transmission (including .pdf) shall be as effective as delivery of a manually executed counterpart of this Ninth Amendment.  
6.4    Successors and Assigns.  This Ninth Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.
6.5    Severability.  Any provision of this Ninth Amendment held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions hereof or thereof; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction.
6.6    No Oral Agreement.  This Ninth Amendment, the Credit Agreement and the other Loan Documents and any separate letter agreements with respect to fees payable to the Administrative Agent constitute the entire contract among the parties hereto relating to the subject matter hereof and thereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof and thereof.  This Ninth Amendment, the Credit Agreement and the other Loan Documents represent the final agreement among the parties hereto and thereto and may not be contradicted by evidence of prior, contemporaneous or subsequent oral agreements of the parties.  There are no unwritten oral agreements between the parties.  
6.7    Governing Law.  THIS NINTH AMENDMENT (INCLUDING, BUT NOT LIMITED TO, THE VALIDITY AND ENFORCEABILITY HEREOF) SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

7

[Signature Pages to Follow]

8

IN WITNESS WHEREOF, the parties hereto have caused this Ninth Amendment to be duly executed effective as of the date first written above.

		
	BORROWER:
	SM ENERGY COMPANY

By:    /s/ A. Wade Pursell
     A. Wade Pursell
     Executive Vice President and Chief 
Financial Officer

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

AGENTS AND LENDERS:    WELLS FARGO BANK, NATIONAL
ASSOCIATION, Individually and as
Administrative Agent

By:     /s/ Sarah Thomas
Name:    Sarah Thomas
Title:    Director    
    

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

BANK OF AMERICA, N.A., Individually and as
Co-Syndication Agent

By:     /s/ Ronald E. McKaig    
Name:    Ronald E. McKaig
Title:    Managing Director

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

JPMORGAN CHASE BANK, N.A., Individually and as Co-Syndication Agent

By:     /s/ Arina Mavilian    
Name:    Arina Mavilian     
Title:    Vice President    

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

COMPASS BANK, Individually and as
Co-Documentation Agent

By:     /s/ Rhianna Disch    
Name:    Rhianna Disch     
Title:    Director    

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

COMERICA BANK, Individually and as
Co-Documentation Agent

By:     /s/ Garrett R. Merrell    
Name:    Garrett R. Merrell     
Title:    Relationship Manager    

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

BARCLAYS BANK PLC

By:     /s/ Jake Lam    
Name:    Jake Lam     
Title:    Assistant Vice President

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

ROYAL BANK OF CANADA

By:     /s/ Kristan Spivey    
Name:    Kristan Spivey 
Title:    Authorized Signatory

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

BOKF, NA DBA BANK OF OKLAHOMA

By:     /s/ Guy Evangelista    
Name:    Guy Evangelista     
Title:    Senior Vice President

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

SANTANDER BANK, N.A.
f/k/a Sovereign Bank 

By:     /s/ Payal Sheth    
Name:    Payal Sheth     
Title:    Vice President

By:     /s/ Puiki Lok    
Name:    Puiki Lok     
Title:    Vice President

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

CAPITAL ONE, NATIONAL ASSOCIATION

By:     /s/ Mason McGurrin    
Name:     Mason McGurrin
Title:    Managing Director

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

DEUTSCHE BANK TRUST COMPANY AMERICAS

By:     /s/ Juan J. Mejia    
Name:     Juan J. Mejia
Title:    Director

By:     /s/ Laureline De Lichana    
Name:     Laureline De Lichana
Title:    Director

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

GOLDMAN SACHS BANK USA

By:     /s/ Ushma Dedhiya    
Name:     Ushma Dedhiya
Title:    Authorized Signatory

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

KEYBANK NATIONAL ASSOCIATION

By:     /s/ George E. McKean    
Name:     George E. McKean
Title:    Senior Vice President

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

THE BANK OF NOVA SCOTIA

By:     /s/ Alan Dawson    
Name:     Alan Dawson
Title:    Director

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

U.S. BANK NATIONAL ASSOCIATION

By:     /s/ John C. Lozano    
Name:     John C. Lozano
Title:    Vice President

[SIGNATURE PAGE TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

ANNEX I
LIST OF COMMITMENTS
	
			
	Name of Lender
	Applicable Percentage
	Commitment

	Wells Fargo Bank, National
Association 
	9.666666667%
	$89,416,666.69

	Bank of America, N.A.
	9.666666667%
	$89,416,666.67

	JP Morgan Chase Bank, N.A.
	9.666666667%
	$89,416,666.67

	Compass Bank
	8.222222222%
	$76,055,555.55

	Barclays Bank PLC
	8.222222222%
	$76,055,555.55

	Royal Bank of Canada
	8.222222222%
	$76,055,555.55

	Comerica Bank
	6.666666667%
	$61,666,666.67

	BOKF, NA dba Bank of Oklahoma
	5.333333333%
	$49,333,333.33

	Santander Bank, N.A.
	5.333333333%
	$49,333,333.33

	Capital One, National Association
	5.333333333%
	$49,333,333.33

	Deutsche Bank Trust Company 
Americas
	5.333333333%
	$49,333,333.33

	KeyBank National Association
	5.333333333%
	$49,333,333.33

	The Bank of Nova Scotia
	5.333333333%
	$49,333,333.33

	U.S. Bank National Association
	5.333333333%
	$49,333,333.33

	Goldman Sachs Bank USA
	2.333333333%
	$21,583,333.33

	TOTAL
	100.00%
	$925,000,000.00

[ANNEX I TO NINTH AMENDMENT TO  
FIFTH AMENDED AND RESTATED CREDIT AGREEMENT – SM ENERGY COMPANY]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]